Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.68B |
| 2 |
Synchrony
SYF
|
+$441M |
| 3 |
Meta Platforms (Facebook)
META
|
+$370M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$349M |
| 5 |
Comcast
CMCSA
|
+$338M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$783M |
| 2 |
Morgan Stanley
MS
|
+$518M |
| 3 |
Lowe's Companies
LOW
|
+$474M |
| 4 |
Visa
V
|
+$425M |
| 5 |
Netflix
NFLX
|
+$419M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 5.01% |
| 2 | Technology | 4.76% |
| 3 | Consumer Discretionary | 3.82% |
| 4 | Industrials | 3.81% |
| 5 | Communication Services | 3.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPMC
5876
PUT
DELISTED
Blueprint Medicines
BPMC
| $631K | ﹤0.01% |
11,700
-7,500
| -39% | -$456K |
|
5877
CALL
Myriad Genetics
MYGN
$290M
| $631K | ﹤0.01% |
21,700
+2,400
| +12% | +$86.3K |
|
5878
ProShares Ultra Health Care
RXL
$89.6M
| $631K | ﹤0.01% |
+27,760
| New | +$713K |
|
|
PRAH
5879
DELISTED
PRA Health Sciences, Inc.
PRAH
| $631K | ﹤0.01% |
6,854
-144,435
| -95% | -$14.6M |
|
5880
PUT
FIVE9
FIVN
$2.47B
| $630K | ﹤0.01% |
14,400
-15,900
| -52% | -$640K |
|
5881
CALL
MannKind Corp
MNKD
$1.24B
| $630K | ﹤0.01% |
594,800
+119,400
| +25% | +$203K |
|
|
HEWY
5882
DELISTED
iShares Currency Hedged MSCI South Korea ETF
HEWY
| $630K | ﹤0.01% |
+26,126
| New | +$678K |
|
5883
NBT Bancorp
NBTB
$2.78B
| $629K | ﹤0.01% |
18,178
-39,637
| -69% | -$1.46M |
|
5884
PUT
Gladstone Capital
GLAD
$446M
| $628K | ﹤0.01% |
+43,000
| New | +$756K |
|
5885
CALL
KNOT Offshore Partners
KNOP
$369M
| $628K | ﹤0.01% |
35,000
+20,900
| +148% | +$422K |
|
5886
PUT
Loews
L
$23.1B
| $628K | ﹤0.01% |
13,800
+5,800
| +73% | +$273K |
|
|
HIBB
5887
PUT
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $628K | ﹤0.01% |
43,900
+29,500
| +205% | +$501K |
|
|
AIV
5888
PUT
Aimco
AIV
$383M
| $627K | ﹤0.01% |
+107,347
| New | +$638K |
|
5889
CALL
Enovis
ENOV
$1.5B
| $627K | ﹤0.01% |
17,430
+8,076
| +86% | +$377K |
|
5890
CALL
Qiagen
QGEN
$8.87B
| $627K | ﹤0.01% |
17,164
+755
| +5% | +$28K |
|
|
SRNE
5891
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $627K | ﹤0.01% |
261,075
+247,468
| +1,819% | +$808K |
|
|
ARRY
5892
PUT
DELISTED
Array Biopharma Inc
ARRY
| $627K | ﹤0.01% |
44,000
-31,600
| -42% | -$479K |
|
5893
CALL
Lindsay Corp
LNN
$1.17B
| $626K | ﹤0.01% |
6,500
+2,900
| +81% | +$283K |
|
5894
CALL
Ultragenyx Pharmaceutical
RARE
$2.61B
| $626K | ﹤0.01% |
14,400
-24,100
| -63% | -$1.32M |
|
|
EQGP
5895
PUT
DELISTED
EQGP Holdings, LP
EQGP
| $626K | ﹤0.01% |
31,400
+20,700
| +193% | +$383K |
|
5896
Minerva Neurosciences
NERV
$219M
| $625K | ﹤0.01% |
11,580
+1,495
| +15% | +$109K |
|
|
VER
5897
CALL
DELISTED
VEREIT, Inc.
VER
| $625K | ﹤0.01% |
17,480
+10,780
| +161% | +$400K |
|
5898
PUT
Leggett & Platt
LEG
$1.32B
| $624K | ﹤0.01% |
17,400
-4,800
| -22% | -$183K |
|
5899
CALL
ITT
ITT
$19.6B
| $623K | ﹤0.01% |
12,900
+1,700
| +15% | +$89.8K |
|
5900
Regional Management Corp
RM
$309M
| $623K | ﹤0.01% |
25,916
-9,302
| -26% | -$252K |
|
Similar funds
Citadel Advisors's Q4 2018 Portfolio in Review
As of Q4 2018, Citadel Advisors held 10,385 positions worth $183B, down 19% from $224B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Citadel Advisors withdrew a net $8B in Q4 2018, closing 1,371 positions and reducing 3,800 holdings. Its most notable exit was Aetna Inc, an estimated $783M position sold in full.
By sector, the portfolio is most concentrated in Financials at 5% of assets, down from 5.9% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Citadel Advisors opened a new position in Assurant worth $99.4M.
- Citadel Advisors's largest Q4 2018 buy was Assurant: 1,111,342 shares worth $99.4M.
- Citadel Advisors added most to Amazon in Q4 2018, an estimated $1.68B increase.
- Citadel Advisors's biggest Q4 2018 reduction was Morgan Stanley, cutting an estimated $518M.
- Citadel Advisors fully exited Aetna Inc in Q4 2018, selling an estimated $783M.
- Citadel Advisors's ten largest holdings make up 24% of its $183B portfolio in Q4 2018.
- Citadel Advisors opened 1,236 new positions and closed 1,371 in Q4 2018.
- Citadel Advisors's portfolio value fell 19% quarter-over-quarter to $183B.
Based on Citadel Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.